9.05
Jade Biosciences Inc (JBIO) 最新ニュース
How Jade Biosciences Inc. stock reacts to inflationary pressuresMarket Activity Recap & Daily Technical Forecast Reports - newser.com
Multi asset correlation models including Jade Biosciences Inc.Index Update & AI Driven Stock Movement Reports - newser.com
Jade Biosciences Inc. stock daily chart insightsJuly 2025 Review & Consistent Profit Trade Alerts - newser.com
Visualizing Jade Biosciences Inc. stock with heatmaps2025 Valuation Update & Safe Capital Growth Tips - newser.com
Jade Biosciences (NASDAQ:JBIO) Research Coverage Started at BTIG Research - Defense World
Visual trend scoring systems applied to Jade Biosciences Inc.2025 Top Gainers & Daily Volume Surge Signals - newser.com
Q3 Earnings Forecast for Jade Biosciences Issued By Wedbush - MarketBeat
BTIG Research Begins Coverage on Jade Biosciences (NASDAQ:JBIO) - MarketBeat
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Analyzing drawdowns of Jade Biosciences Inc. with statistical toolsAnalyst Upgrade & High Accuracy Swing Trade Signals - newser.com
Jade Biosciences stock initiated with Buy rating at BTIG on APRIL inhibitor potential - Investing.com Canada
BTIG Initiates Coverage of Jade Biosciences (JBIO) with Buy Recommendation - Nasdaq
BTIG Initiates Jade Biosciences at Buy With $28 Price Target - MarketScreener
Jade Biosciences (NASDAQ:JBIO) Receives Sell (E-) Rating from Weiss Ratings - MarketBeat
Jade Biosciences offers $135 million equity through private placement - MSN
Jade Biosciences discloses JADE-201 for autoimmune diseases - BioWorld MedTech
Jade Biosciences Announces JADE201, a Potentially - GlobeNewswire
Jade Biosciences Secures $135 Million In PIPE Deal - Finimize
Jade Biosciences Unveils JADE201 Antibody to Potentially Treat Autoimmune Diseases - MarketScreener
Jade Biosciences unveils JADE201 antibody targeting BAFF-R By Investing.com - Investing.com Nigeria
Jade Biosciences secures $135 million in private financing By Investing.com - Investing.com Canada
Jade Biosciences Secures $135 Million in Private Placement - TipRanks
Jade Biosciences unveils JADE201 antibody targeting BAFF-R - Investing.com
Jade Biosciences Announces JADE201, a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases - The Manila Times
Jade Biosciences Announces $135 Million Private Placement - GlobeNewswire
Jade Biosciences Announces $135 Million Private Placement - GlobeNewswire Inc.
Real time alert setup for Jade Biosciences Inc. performanceJuly 2025 Price Swings & Expert Curated Trade Setup Alerts - newser.com
How to integrate Jade Biosciences Inc. into portfolio analysis toolsQuarterly Growth Report & Safe Investment Capital Preservation Plans - newser.com
Jade Biosciences, Inc. announced that it expects to receive $135 million in funding - MarketScreener
Tick level data insight on Jade Biosciences Inc. volatility2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
Is Jade Biosciences Inc. stock vulnerable to regulatory risksJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - newser.com
How strong is Jade Biosciences Inc. stock balance sheetQuarterly Earnings Report & High Conviction Buy Zone Alerts - newser.com
What drives Jade Biosciences Inc stock priceCandlestick Pattern Analysis & Minimize Portfolio Damage with Warnings - earlytimes.in
大文字化:
|
ボリューム (24 時間):